Powered by: Motilal Oswal
2026-08-19 11:45:22 am | Source: Accord Fintech
Jubilant Ingrevia inches up on inking pact to acquire 40% stake in Zettaone Technologies India
Jubilant Ingrevia inches up on inking pact to acquire 40% stake in Zettaone Technologies India

Jubilant Ingrevia is currently trading at Rs. 726.75, up by 0.85 points or 0.12% from its previous closing of Rs. 725.90 on the BSE.

The scrip opened at Rs. 737.75 and has touched a high and low of Rs. 737.75 and Rs. 722.05 respectively. So far 669 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 794.95 on 22-Jul-2026 and a 52 week low of Rs. 535.30 on 02-Mar-2026.

Last one week high and low of the scrip stood at Rs. 747.85 and Rs. 714.00 respectively. The current market cap of the company is Rs. 11562.22 crore.

The promoters holding in the company stood at 45.22%, while Institutions and Non-Institutions held 31.49% and 23.28% respectively.

Jubilant Ingrevia has entered into a binding agreement with Zettaone Technologies India for the acquisition of a 40% strategic stake for Rs 189.2 crore. Following completion of the proposed acquisition, Zettaone Technologies will become an associate company of Jubilant Ingrevia. The acquisition is proposed to be completed in two tranches, with the first tranche expected to close by November 2026 and the second tranche is expected to close by September 2027.

This acquisition will allow the company to capitalize on its proven manufacturing and customer-centric capabilities in CDMO space, while further strengthening its engagement with customers across the electronics and semiconductor value chain.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here